Generalizability of the REDUCE-IT trial in patients with stable coronary artery disease

Picard, F., Bhatt, D. L., Ducrocq, G., Elbez, Y., Ferrari, R., Ford, I. , Tardif, J. C., Tendera, M., Fox, K. M. and Steg, P. G. (2019) Generalizability of the REDUCE-IT trial in patients with stable coronary artery disease. Journal of the American College of Cardiology, 73(11), pp. 1362-1364. (doi:10.1016/j.jacc.2019.01.016) (PMID:30819552)

[img] Text
178198.pdf - Accepted Version
Restricted to Repository staff only until 25 February 2020.

159kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Additional Information:This study was in part supported by Servier and Amarin Pharma.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ford, Professor Ian
Authors: Picard, F., Bhatt, D. L., Ducrocq, G., Elbez, Y., Ferrari, R., Ford, I., Tardif, J. C., Tendera, M., Fox, K. M., and Steg, P. G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
Journal Name:Journal of the American College of Cardiology
Publisher:Elsevier
ISSN:0735-1097
ISSN (Online):1558-3597
Published Online:25 February 2019
Copyright Holders:Copyright © 2019 American College of Cardiology Foundation
First Published:First published in Journal of the American College of Cardiology 73(11):1362-1364
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record